Across TCGA pan-cancer cohorts, WHAMMP2 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated WHAMMP2 data layer compared with 16 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher WHAMMP2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated WHAMMP2 expression acts as an unfavorable survival marker.
COAD are the cancer types where WHAMMP2 Mutation most reproducibly stratifies survival.